MBX Biosciences Inc (NASDAQ: MBX) is -46.34% lower on its value in year-to-date trading and has touched a low of $9.65 and a high of $27.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MBX stock was last observed hovering at around $10.54 in the last trading session, with the day’s loss setting it -0.65%.
Currently trading at $9.89, the stock is -40.65% and -47.32% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.23 million and changing -6.17% at the moment leaves the stock -51.97% off its SMA200. The firm has a 50-day simple moving average (SMA 50) of $18.7744 and a 200-day simple moving average (SMA200) of $20.589195.
The stock witnessed a -48.33% in the last 1 month and extending the period to 3 months gives it a -59.12%, and is -27.76% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.15% over the week and 11.60% over the month.
Distance from 52-week low is 2.49% and -64.04% from its 52-week high.
.
MBX Biosciences Inc (MBX) Top Institutional Holders
The shares outstanding are 33.38M, and float is at 16.24M with Short Float at 10.31%.
MBX Biosciences Inc (MBX) Insider Activity
The most recent transaction is an insider purchase by Mathers Edward T, the company’s Director. SEC filings show that Mathers Edward T bought 500,000 shares of the company’s common stock on Sep 16 ’24 at a price of $16.00 per share for a total of $8.0 million. Following the purchase, the insider now owns 3.61 million shares.
MBX Biosciences Inc disclosed in a document filed with the SEC on Sep 16 ’24 that BASKETT FOREST (10% Owner) bought a total of 500,000 shares of the company’s common stock. The trade occurred on Sep 16 ’24 and was made at $16.00 per share for $8.0 million. Following the transaction, the insider now directly holds 3.61 million shares of the MBX stock.
Still, SEC filings show that on Sep 16 ’24, Behbahani Ali (10% Owner) acquired 500,000 shares at an average price of $16.00 for $8.0 million. The insider now directly holds 3,614,486 shares of MBX Biosciences Inc (MBX).
